Zoetis Sees Softer Pet Health Demand, But Adapting Commercial Strategy to Navigate Headwinds
Zoetis Inc. (NYSE: ZTS ) reported second-quarter adjusted earnings of $1.87 per share, beating the consensus of $1.86. The animal health company reported sales of $2.468 billion, missing the consensus of $2.502 billion. Revenue was flat year over year, decreasing 1% on an organic operational basis. Zoetis Sees Softer C